Time to act on trials
Many of the worst economic and bureaucratic burdens that have proved such a deterrent to multi-country clinical trials look set to be addressed with the overhaul of the EU Clinical Trials Directive, but should we [more]
Many of the worst economic and bureaucratic burdens that have proved such a deterrent to multi-country clinical trials look set to be addressed with the overhaul of the EU Clinical Trials Directive, but should we [more]
Patients are being let down by a failure to integrate the knowledge we have to get the best possible results for each individual patient and for cancer patients as a whole. Vincenzo Valentini, the ESTRO [more]
The odds that a woman will be told she needs a reoperation after conservative breast surgery vary between treatment centres, prompting calls for international guidelines and greater oversight of surgeons. For many women with [more]
Cancer poses a rising threat to global health as well as the world economy. International experts have agreed on a strategy that can meet the challenge. They are now calling on world leaders to wake [more]
Journalists who write about their own cancer journeys are able to convey important insights in a language that people understand and are eager to read It is not surprising that a lot of journalists [more]
Helping patients make the best of their lives after treatment starts with thinking ahead before treatment and tailoring support for as long as it is needed. A leader in the field talks about key issues [more]
The isolation that is essential to the physical health of people undergoing stem cell transplantation can be terrible for their mental health at a time of great stress. Patients are giving the thumbs up to [more]
A retrospective cohort study has shown that pancreatic radiation is a risk factor for diabetes in survivors of paediatric cancer. This validates and refines prior epidemiological observations of diabetes after radiation to the abdomen and [more]